Sign in
REPH Stock Price, Chart, Stats & News
Recro Pharma, Inc.
Save
Recro Pharma, Inc. (REPH) does not currently pay a dividend.
177.42M
Market cap
–
Current P/E
–
Forward P/E
REPH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 19.17% |
Operating margin | -3.78% |
Pretax margin | -13.89% |
Net margin | -14.03% |
Effective tax rate | -1.00% |
ROA | -8.65% |
ROE | -22.40% |
D/E | 0.72x |
Interest coverage ratio | 0.36x |
REPH valuation
P/E | – |
P/S | 1.87x |
P/B | 3.39x |
P/CF | -198.04x |
P/FCF | -19.20x |
P/OCF | -198.04x |
PEG | -0.15x |
EV multiple | -10.11x |
About
Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U. S. and international clients.
Similar securities
Based on sector and market capitalization
Report issue